Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Cancer Medicine|June 27, 2019
Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE geneHitoshi Hino, Akio Shiomi, Masatoshi Kusuhara, et al.
Molecular and Cellular Biochemistry|March 5, 2017
Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumorsShumpei Ohnami, Keiichi Ohshima, Takeshi Nagashima, et al.
Scientific Reports|February 23, 2022
Tumor cell enrichment by tissue suspension enables detection of mutations with low variant allele frequency and estimation of germline mutationsKeiichi Hatakeyama, Koji Muramatsu, Takeshi Nagashima, et al.
Scientific Reports|June 9, 2018
Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutationsKeiichi Hatakeyama, Keiichi Ohshima, Takeshi Nagashima, et al.
Cancer Science|June 2, 2019
Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapyKeiichi Hatakeyama, Takeshi Nagashima, Keiichi Ohshima, et al.
International Journal of Clinical Oncology|September 17, 2024
Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort studyShunsuke Kasai, Hiroyasu Kagawa, Keiichi Hatakeyama, et al.
Biomedical Research (Tokyo, Japan)|August 6, 2023
Comparative analysis of tumor content estimation methods based on simu- lated tumor samples identified their impact on somatic variant detection in cancer whole genome sequencingTakeshi Nagashima, Kenichi Urakami, Yuji Shimoda, et al.
Biomedical Research (Tokyo, Japan)|June 15, 2018
Tumor mutational burden analysis of 2,000 Japanese cancer genomes using whole exome and targeted gene panel sequencingKeiichi Hatakeyama, Takeshi Nagashima, Kenichi Urakami, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 19, 2020
Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysisKenichi Nakamura, Keiichi Hatakeyama, Kenichiro Furukawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 23, 2020
MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancerKeiichi Fujiya, Masanori Terashima, Keiichi Ohshima, et al.
Pageof 7